Log In
BCIQ
Print this Print this
 

CTX-0294945

  Manage Alerts
Collapse Summary General Information
Company Cancer Therapeutics CRC Pty. Ltd.
DescriptionSmall molecule inhibitor of focal adhesion kinase (FAK)
Molecular Target Focal adhesion kinase (FAK)
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationBreast cancer
Indication DetailsTreat triple-negative breast cancer (TNBC)
Regulatory Designation
PartnerCancer Research Technology Ltd.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today